One limitation of these studies was that they included different patient diagnosis (PD, essential tremor, dystonia), modality treatments (DBS, pallidotomy or thalamotomy), and targets (Stn, Gpi and thalamus). Here, EEF1A2 is linked to Parkinson disease.